PRVL - Prevail Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Prevail Therapeutics's activity chart (see below) currently has 20 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 70.91% of the time, taking 191.45 days on average.

Most recent stock forecast was given by from WEDBUSH on 23-Dec-2020. First documented stock forecast 15-Jul-2019.

Best performing analysts who are covering PRVL - Prevail Therapeutics:

Laura Chico Jeffrey Hung Christopher Raymond Paul Matteis Neena Bitritto-Garg

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Jul-2019

$22

$22

5 years 10 months 29 days ago
(23-Dec-2020)

2/5 (40%)

$-1.18 (-5.09%)

234

Buy Since 16-Jul-2020

$23

5 years 11 months 4 days ago
(17-Dec-2020)

2/2 (100%)

$-0.17 (-0.73%)

84

Buy Since 06-Mar-2020

$24

5 years 11 months 6 days ago
(15-Dec-2020)

0/2 (0%)

$1.25 (5.49%)

Buy Since 09-Apr-2020

$24.5

$20

5 years 11 months 6 days ago
(14-Dec-2020)

4/5 (80%)

$1.75 (7.69%)

206

Buy Since 15-Jul-2019

$20

$20

6 years 10 months 25 days ago
(27-Dec-2019)

2/2 (100%)

$4.19 (26.50%)

437

Show more analysts

Please expand the browser size to see the chart

What is PRVL (Prevail Therapeutics) average time for price targets to be met?

On average it took 191 days for the stock forecasts to be reached, with an average price target met ratio of 70.91%.

Which analyst most recently updated their price target on PRVL (Prevail Therapeutics)?

Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?

has 0 price targets and 0 ratings on PRVL

Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?

Christopher Raymond with the highest potential upside of $1.5

Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?

Tazeen Ahmad with the lowest potential downside of -$8
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?